Article metrics

Download PDFPDF
A Phase 2 Evaluation of Irofulven as Second-line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Trial

 

Online download statistics by month:

Online download statistics by month: January 2019 to January 2023

AbstractFullPdf
Jan 2019400
Feb 20191200
Mar 20192301
Apr 2019700
May 20191200
Jun 20191000
Jul 20191200
Aug 2019600
Sep 2019400
Oct 2019600
Nov 20191302
Dec 20191600
Jan 20201601
Feb 2020400
Mar 20202602
Apr 2020400
May 20201800
Jun 20201000
Jul 20201700
Aug 20203000
Sep 20203003
Oct 2020600
Nov 2020800
Dec 20202000
Jan 20212301
Feb 20211800
Mar 2021400
Apr 20211200
May 2021700
Jun 2021100
Aug 2021001
Oct 20212000
Nov 20211200
Dec 20211200
Jan 20222600
Feb 20222000
Mar 20223300
Apr 20221401
May 20223800
Jun 20223401
Jul 20223600
Aug 20225600
Sep 20224201
Oct 20224600
Nov 20225002
Dec 20222000
Jan 20231800
Total856016